AtaiBeckley (ATAI) Return on Assets (2021 - 2026)

AtaiBeckley (ATAI) posted quarterly Return on Assets of 0.0% for Q1 2026.

AtaiBeckley (ATAI) Return on Assets (2021 - 2026) Analysis & Trends

AtaiBeckley's Return on Assets history runs 1 years deep, the most recent figure standing at 0.0% for Q1 2026.

Quarterly Return on Assets fell 2.0% year-over-year to 0.02% in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.02% (down 2.0% YoY) and the FY2024 annual result came in at 0.01%, down 1.0% from the prior year.
Return on Assets eased to 0.02% in Q1 2025 per ATAI's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Assets peaked at 0.0% in Q1 2024 and troughed at 2.03% in Q3 2021.
A 5-year average of 0.39% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
The sharpest annual moves came in 2022 and 2025: Return on Assets jumped 48 bps in 2022, then declined 2 bps in 2025.
Over 5 years, Return on Assets stood at 0.49% in 2021, then soared by 99 bps to 0.0% in 2022, then jumped by 68 bps to 0.0% in 2023, then sank by 78 bps to 0.0% in 2024, then tumbled by 668 bps to 0.02% in 2025.
According to Business Quant data, Return on Assets over the past three periods registered 0.02%, 0.0%, and 0.0% for Q1 2025, Q2 2024, and Q1 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.00%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.01%
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.00%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	0.00%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.00%
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	0.00%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.00%
10	AtaiBeckley	2.69 Bn	2.69 Bn	-	-

Download Data